RECURRENT HEAD AND NECK CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to boost immune System's fight against tough cancer
Disease control OngoingThis study is testing if adding a drug called ramucirumab to the immunotherapy drug pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer that has returned or spread. The goal is to see if the combination helps shrink tumors and control…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Faster radiation vs. standard care for tough head & neck cancers
Disease control TerminatedThis study compares two different radiation therapy methods for patients whose head and neck cancer has returned and cannot be removed by surgery. One method delivers high-precision radiation in just 5 sessions, while the other uses a more standard approach over 6-7 weeks. The ma…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC